Pneumococcal Vaccines Concept

Vocabulary Service

MeSH

Overview

subject area of

A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre Journal Articles
Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015 Journal Articles
An Appraisal of the Evidence Underlying Performance Measures for Community-acquired Pneumonia Journal Articles
Assessing the diagnostic accuracy of PCR-based detection ofStreptococcus pneumoniaefrom nasopharyngeal swabs collected for viral studies in Canadian adults hospitalised with community-acquired pneumonia: a Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research (CIRN) study Journal Articles
Community acquired pneumonia. Journal Articles
Community acquired pneumonia. Journal Articles
Community acquired pneumonia. Journal Articles
Community-acquired pneumonia. Journal Articles
Direct Streptococcus pneumoniae real-time PCR serotyping from pediatric parapneumonic effusions Journal Articles
How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda Journal Articles
Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use. Journal Articles
Immunization for the Elderly Journal Articles
Influenza and Pneumococcal Immunization Journal Articles
Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations Journal Articles
Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs Journal Articles
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation Journal Articles
Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States Journal Articles
Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults Journal Articles
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18–49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors Journal Articles
Pneumococcal Immunization in Older Adults: Implications for the Long-Term–Care Setting Journal Articles
Pneumococcal Serotypes in the Elderly Journal Articles
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023 Journal Articles
Pneumococcal vaccination and risk of myocardial infarction Journal Articles
Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011 Journal Articles
Pneumonia in the elderly Journal Articles
Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study Journal Articles
Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study Journal Articles
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay Journal Articles
Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016–2019) Journal Articles
Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN) Journal Articles
Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin Journal Articles
The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials Journal Articles
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Journal Articles
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Journal Articles
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. Journal Articles
Vaccine strategies for prevention of community-acquired pneumonia in Canada Journal Articles